IGF2 and psychiatric disorder: In this context, recent evidence displays insulin-like growth factor 2 (IGF2)as a critical target for psychiatric diseases by playing a pivotal role in neurogenesis and in the antidepressant responses of the most widely used classical antidepressant drugs.